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Abstract 
Acceptability of medicines is critical for effective pharmacotherapy. The aim of this study was to 
investigate the oral sensory properties of tablet coatings to determine how mouthfeel can improve 
acceptability. A randomised double-blind study was performed in 84 adult volunteers (51% ≥55 
years). Each participant received 4 placebo tablets (3 coated and 1 uncoated) to evaluate (i) ease of 
swallowing and (ii) palatability. Visual analogue scales (VAS) were used to capture sensory 
parameters. Acceptability was assessed using the following parameters: ease of swallowing; amount 
of water taken with the tablet; rank order of preference; roughness; adhesiveness and slipperiness. 
Ease of swallowing was determined to be the most sensitive measure of acceptance. The best 
coating was the one that was reported to be the most slippery and smooth. 
The presence of a coating improved ease of swallowing, mouthfeel and overall palatability. This 
study demonstrates that slippery coatings improve acceptability of tablets. The study also 
demonstrates the value of VAS to measure the sensory attributes of coated tablets.  
 
Keywords: patient acceptability; swallowability; sensory analysis; palatability; mouthfeel; coated 
tablets  
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1 Introduction 
Patient acceptability of medicines is fundamental in the development of pharmaceutical dosage 
forms (Liu et al., 2014). Assessing acceptability of medicinal products in their target population is a 
requirement of the European Medicines Agency in order to obtain a marketing approval (EMA, 2006;  
2017). For oral drug delivery, tablets are the most common and preferred choice of dosage form 
(Mohr, 2009). For any oral formulation, ease of swallowing is an important determinant of patient 
acceptability. Ease of swallowing is affected by both medicinal product features (i.e. dosage size, 
shape, slipperiness of the coating), as well as the patient’s ability (physiological and/or psychological) 
to swallow (EMA, 2017). In general, larger solid oral dosage forms are reported to be more difficult 
to swallow but shape also has an influence. Round tablets have been reported to cause fewer 
difficulties compared to oblong and oval tablets (Schiele et al., 2013).  
Another determinant of acceptability is palatability. The main factors that affect palatability of solid 
oral dosage forms are taste, texture and mouthfeel (Fields et al., 2015; Liu et al., 2016; Schiele et al., 
2013). While taste is a sensation caused by chemical interaction of formulation components with 
taste buds on the tongue, texture and mouthfeel are more complex and multifactorial in nature. 
Texture embraces “all the mechanical, geometrical and surface attributes of a product perceptible 
by means of mechanical, tactile, and, where appropriate, visual and auditory receptors”, as defined 
by the International Standards Organisation (ISO, 1994). Whereas mouthfeel encompasses the 
tactile properties perceived from the point a formulation is placed in the mouth to when it is 
swallowed (Guinard and Mazzucchelli, 1996) 
Many manufacturers apply film coatings to tablets. Reasons for this include: aiding identification; 
improved stability; control of drug release rates and taste masking of bitter drugs (Joshi and Petereit, 
2013). Typical polymers used include hydroxypropyl methylcellulose (HPMC); polyvinyl alcohol 
(PVA); polyvinyl alcohol - polyetheylene glycol graft copolymer (PVA-PEG); acrylic copolymers with 
plasticizing agents such as polyethylene glycol, triacetin or others. Film coatings can make a tablet 
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more palatable by taste masking and provision of a smooth outer surface texture (Fields et al., 2015) 
to improve mouthfeel, which can improve acceptability. In addition, they can improve ease of 
swallowing of a tablet. By inhibiting the disintegration of the tablet in the mouth, a polymer film 
coating enables a tablet to be swallowed intact and the polymer layer can enhance the gliding 
properties of the tablet surface within the mouth during the swallowing action i.e. provide a slippery 
layer (Mahdi and Maraie, 2015). Multiple studies have confirmed that coating a solid dosage form 
can improve the swallowing experience and taste (El Edelbi et al., 2015; Mahdi and Maraie, 2015; 
Uloza et al., 2010).  
Unpleasant taste and mouthfeel have been found to impact patient adherence in paediatric 
(Venables et al., 2015) and adult populations (Schiele et al., 2013). Yet, there is limited 
understanding of which mouthfeel attributes have the largest impact on the acceptance of solid 
dosage forms. Similarily, awareness of tablet sensory characteristics that are discernible by patients 
is needed. Evaluation of taste and texture is typically undertaken using sensory analysis.  Whilst food 
sensory analysis is well studied, the field of pharmaceutical sensory analysis lacks clear guidance 
(Tuleu, 2016). Pharmaceutical sensory studies conducted to date use a range of methodologies and 
some levels of discrepancies exist amongst them, such as: the number of subjects involved, type of 
control sample, scales and measures used, definition of acceptance criteria, and level of training of 
the participants. Further work is needed to determine methodology for testing the appropriateness 
of drug products (Drumond et al., 2017). 
Previous clinical swallowing studies used various methods, to collect data: as observations (Kluk and 
Sznitowska, 2014); using a descriptor scale (El Edelbi et al., 2015) or VAS (visual analogue scale) 
(Hayakawa et al., 2016). The VAS provides continuous data, which is suitable for statistical analysis 
and allows detection of small differences between samples (Mistry et al., 2017). Similar 
methodologies have been used to assess the mouthfeel of medicines. Notable examples include in 
vivo evaluation of perceived grittiness and roughness of oral dosage forms depending on the 
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formulation factors (i.e. particle size) (Kimura et al., 2015; Lopez et al., 2016). Lopez et al. (2016) 
concluded that the perceived oral grittiness of solid multi-particulate formulations is significantly 
reduced when particles are dispersed in a viscous vehicle, while Kimura et al. (2015) established that 
a rough mouthfeel was more intense for ODT with granule size ≥200 μm. There are very few reports 
of studies performed that evaluate the palatability, excluding taste, of oral dosage forms. The 
objective of this study was to investigate the ease of swallowing and oral sensory properties of 
tablet coatings applied to placebo tablets. The study used a crossover, single centre design to assess 
the ease of swallowing and sensory perception of the mouthfeel of placebo tablets coated with 
different film coatings vs.  uncoated ones. The oral sensory perception of tablet-coating attributes 
that are critical to improve swallowing and acceptability are as yet unexplored. This study 
investigates the effect of tablet coatings on swallowability and mouthfeel in an adult population with 
an emphasis on older (>55 years) adults. These data will inform the application of coatings which 
optimise acceptability of tablets.  
2 Materials and methods  
2.1 Study population and setting 
The study was approved by the Ethical Committee of the University of Birmingham (ERN_17-0883 
(17-1074)). All sessions were conducted within the premises of the School of Pharmacy at the 
University of Birmingham. The participants were recruited from the University of Birmingham and 
associated networks via advertisements and newsletters. The eligibility criteria included non-
smoking, healthy adults between 18 and 75 years of age, who did not self-report any conditions that 
might compromise their taste or smell, nor any issues in ability to swallow a tablet. Prior to the study 
written consent was collected from all participants.  
The sample size analysis showed that to detect a 10 point difference on the scale with a power of 
80% and α = 0.05 there was a need for 38 evaluations per sample. An older population (≥55 years) 
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was targeted to better reflect the population who take the most medication and may have a higher 
incidence of swallowing disorders (NHS Digital, Baijens et al., 2016; 2017). 
2.2 Background questionnaire 
Participants completed a background questionnaire to record demographics including: age range; 
gender; and previous problems with swallowing tablets including what caused these difficulties. 
Information on current tablet/capsule intake was also recorded. (The background questionnaire is 
available in Appendix A).  
2.3 Materials 
White capsule shaped placebo tablets (caplets) were manufactured under GMP conditions and used 
in this study. The caplet shape and large dimension tablets, 19 x 9 x 7 mm, were selected for this 
study to reflect the tablet features most likely to cause swallowing problems (Schiele et al., 2013). 
Tablets were prepared by direct compression on a 27-station compression machine (CMBGD-27/MT, 
CADMACH, India) fitted with 12 sets of D-tooling and 950mg target weight. Tablet properties were 
as follows, hardness: 125 ± 4 N, average weight: 951.6 mg ± 3.0%, friability: 0.1% and disintegration 
time: 1 min 53 seconds. These placebo tablets were composed of: lactose monohydrate (69%), 
microcrystalline cellulose (15%), Starch 1500® (Partially Pregelatinized Maize Starch, 15%), colloidal 
silica (0.5%) and magnesium stearate (0.5%). 
The average porosity (P) of the tablets was 23%, as calculated from density (ρ): 𝑃 = (1 −
𝜌𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡
𝜌𝑡𝑟𝑢𝑒
) × 100, where 𝜌𝑎𝑝𝑝𝑎𝑟𝑒𝑛𝑡 = 1.18 
𝑔
𝑐𝑚3⁄  , and 𝜌𝑡𝑟𝑢𝑒 = 1.54
𝑔
𝑐𝑚3⁄  . Tablets were then 
coated (coating equipment: NEOCOTA 40D dual pan coater) under GMP conditions using the 
Opadry® film coating systems; (Opadry white, Opadry EZ white and Opadry EZ clear (Colorcon, USA) 
(Table 1). These aqueous based film coatings were sprayed onto tablets providing a weight gain of 
3% (w/w) film coat, and 1% (w/w) clear top coat (in one case), under the process conditions shown 
in Table 2. 
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2.4 Tablet sample assessment 
Both (i) ease of swallowing and (ii) palatability of placebo tablets were assessed within a single visit. 
In both aspects of the study participants received four tablets. To reduce carry over and sequential 
bias the following methods were used: four samples were presented in a randomized order in all 
possible sequences, and a palate cleanser was given before each sample. Palate cleansing entailed 
drinking room temperature spring water, followed by a piece of lightly salted cracker (Jacob’s, or 
Schar gluten free) and followed again by room temperature spring water (Lucak and Delwiche, 
2009).  
During the evaluation of ease of swallowing, the participants swallowed tablet samples in their usual 
manner, with unlimited access to room temperature spring water. The participants were not given 
specific instruction on the amount of water they should drink but advised to take the tablets as they 
would normally. The amount of water consumed for each tablet swallowed was recorded. This was 
calculated by subtracting the weight of the cup of water before and after taking the sample 
(ρH2O ≈ 1 g/mL). For each sample, participants measured the time taken to swallow each tablet using 
stopwatches. The time taken to swallow each tablet was measured by each participant from the 
moment the tablet was put into mouth until the perception of complete swallowing.  The ease of 
swallowing was assessed by each participant using a 100 mm visual analogue scale (VAS) as shown in 
Figure 1 (the assessment form is available in Appendix B). Additionally, incidents of tablet arrest in 
the mouth or throat were recorded. After swallowing of all four samples, participants ranked the 
tablets on an ordinal scale of 1–4 (score 1 corresponding to the easiest to swallow, score 4 to the 
hardest to swallow), ties were not allowed. Then participants indicated which tablets were 
acceptable as a yes/no option for each of the four tablets. 
During the palatability part of the study, participants were instructed to hold the tablet in their 
mouth for minimum of 10 seconds and feel the tablet surface with their tongue and palate. After 
each sample, the mouthfeel was assessed using 3 VAS with the following anchor phrases: roughness 
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(“Smooth” vs. “Rough”), adhesiveness (“Doesn’t stick at all” vs. “Tablet is very sticky”), slipperiness 
(“Tablet slips easily” vs. “Stays in place”). Finally, overall palatability was assessed on a VAS 
(“Pleasant” vs. “Unpleasant”) (the assessment form is available in Appendix C). 
2.5 Data analysis 
Statistical analysis was conducted to explore differences between samples, and the relationship 
between demographic data and participants’ responses. The participants’ marks on the VAS were 
transcribed into scores (from 0 to 100). Firstly, Friedman’s ANOVA test (non-parametric test for 
related samples) was performed to screen for differences between samples (p<0.05 was deemed 
significant). Further, Wilcoxon’s signed rank test was used to determine differences between 
individual sample pairs. For a pairwise comparison of the 3 coated samples (excluding the uncoated 
tablet) p<0.0167 level was used (derived from p=0.05 divided by 3 combinations of pairs).  
Furthermore, the participants were divided into two groups, ≤54 years and ≥55 years, to analyse the 
effect of age. Pearson Chi2 test was used to analyse demographic data (p<0.05 was deemed 
significant). For comparison of VAS scores between different populations the Mann-Whitney U test 
was used (non-parametric test for independent samples), p<0.05 was deemed significant. The 
probability of the tablet arrest in relation to the sample taken was evaluated as odds ratio (OR) with 
95% confidence intervals (CI). 
The relationship between acceptability of a sample and given VAS score was evaluated using the 
Mann-Whitney U test (p<0.05 was deemed significant). Finally, Receiver Operating Characteristic 
(ROC) analysis was used to determine the cut off VAS value for each parameter that defined as 
acceptable product. Data analysis was undertaken with SPSS statistical software version 24 (IBM 
Corp.). 
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3 Results 
3.1 Participant demographics  
The study recruited 84 non-smoking, healthy adults between 18 and 75 years of age. All participants 
finished both parts of the study. One subject was excluded from data analysis as they did not adhere 
to the study protocol (i.e. did not undertake palate cleansing between samples) and generated 
multiple outliers (defined as values >1.5x interquartile value). Data from a total of 83 participants 
was analysed, 49 of them (59.0%) were female (Table 3). Participants over 55 years old accounted 
for the 51% of the study population. The number of medications taken daily was found to be age-
related (χ2 (2) = 11.899, p<0.01). Sixteen (19.5%) participants reported taking four or more 
medicines daily, with a majority of them being over 55 years old.  
3.2 Ease of swallowing assessment 
Prior to subsequent analysis of data, it was confirmed that the order of taking tablets did not 
influence the VAS score given by the participant (Friedman’s ANOVA test, p>0.05). VAS data was not 
normally distributed (Shapiro-Wilk test, p<0.05), therefore median values were compared.  The VAS 
results showed that the uncoated tablet (median VAS: 66 mm) was more difficult to swallow than 
any of the coated tablets (median VAS: 85-87 mm), χ2 (3) = 52.545, p<0.001 (Figure 2). While the 
coated tablets were all similarly easier to swallow [χ2 (2) = 4.315, p=0.116]. The rank of ease of 
swallowing placed tablet samples in the following order: EZ-EZ > EZ > Opadry > Uncoated.  Most 
participants ranked the coated tablet samples as their first choice, EZ-EZ (37.8%), EZ (25.6%), and 
Opadry (22%). Only 14.6% of participants ranked the uncoated tablet first, with the majority (64.6%) 
ranking it as the most difficult to swallow of all the tablets. 
Participants drank between 0 mL to 125 mL of water to swallow each tablet. The median volume of 
water needed to swallow coated tablets was 28.8 mL, compared to 35.9 mL for the uncoated ones 
[χ2 (3) = 20.678, p<0.001]. The time taken to swallow tablet samples ranged from 1 to 49 seconds 
with uncoated tablets taking longer to swallow than coated ones [χ2 (3) = 14.855 p<0.01].  
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With a fifth (20.5%) of the 332 tablets tested, participants reported tablet arrest i.e. the feeling that 
the tablet was stuck, either in their mouth or during the swallow. For the uncoated tablets 41% were 
reported, whereas the incidence for all coated tablets was only 14% (OR 0.229, CI 0.130-0.404). The 
incidence of tablet arrest inversely correlated with the ease of swallowing VAS and rank (U = 2119, 
p<0.001, and U = 3111, p<0.001, respectively). Moreover, in the event of tablet arrest more water 
and more time to swallow the tablet were necessary (Z (1) = -2.349, p<0.05, and Z (1) = -4.160, 
p<0.001, respectively). The occurrence of tablet arrest was neither age nor gender related (χ2 (1) = 
0.127, p=0.722, and χ2 (1) = 0.123, p=0.726, respectively). 
3.3 Mouthfeel and palatability assessment: quantitative analysis of scales 
Comparison of the median VAS scores for smoothness, stickiness, slipperiness and palatability of all 
samples are presented in Figure 3. All four parameters showed the uncoated tablet to be statistically 
different from the coated tablets (Wilcoxon’s test, p<0.01). With the exception of slipperiness, 
participants were not able to perceive differences between the three coated tablets.  
3.4 Demographic related aspects of ease of swallowing and palatability 
3.4.1 History of issues with swallowing tablets 
Over a quarter of the study population reported previous issues in swallowing tablets (n= 22/83). 
The reasons why participants reported issues in swallowing tablets previously are shown in Table 4. 
Those, who reported issues in tablet swallowing, rated the tablets on VAS as more difficult to 
swallow than those who did not declared any issues (U = 8633.5, p<0.05). 
3.4.2 Age  
The occurrence of problems with swallowing tablets was found to be age related, with younger 
participants (≤54 years) reporting the difficulties more often than older participants (≥ 55 years) (χ2 
(1) = 4.530, p<0.05). Older participants took more time (median 7.5 s vs. 6 s), but less water to 
swallow the tablet (median 26.4 mL and 34.2 mL respectively) compared to the younger 
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participants. Also, the instances of using no water at all were more common amongst the older than 
the younger population (10 cases (6.1%) vs. 4 cases (2.5%)).  
The ability to distinguish between the samples differed between age groups. Both, young and old, 
could differentiate the coated from uncoated tablets. The younger group could distinguish between 
coated samples using scales of roughness, adhesiveness, slipperiness and palatability. However, the 
older population could only differentiate the roughness between EZ-EZ and EZ coated sample, where 
EZ-EZ samples had lower roughness. 
3.4.3 Gender 
The study found no correlation between gender and occurrence of problems with swallowing tablets 
(χ2 (1) = 0.004, p=0.951). Neither, the time or water needed to take the tablet was gender related. 
Looking at the scores given on the VAS scale, there was no influence of gender, except for the 
palatability scale. Males tended to score the uncoated tablet as more pleasant than females did 
(median 50 vs. 36; U = 545, p<0.01). In general, females were better able to differentiate the tablets 
than males. While females rated the uncoated tablet significantly less pleasant than coated ones 
(Wilcoxon’s test, p<0.0167), males gave similar palatability scores to all of the samples (Wilcoxon’s 
test, p>0.0167). 
3.5 Determinants of the acceptability  
In contrast to the uncoated tablet (66%), almost all of the participants reported that the coated 
tablets would be acceptable to take on a daily basis (EZ-EZ 96%, EZ 93% and Opadry 95%). The score 
comparison of the acceptable and unacceptable tablets showed an association with the following 
parameters: ease of swallowing; amount of water taken with the tablet; rank; roughness; 
adhesiveness and slipperiness (Table 5). The VAS scores that best separated the parameters listed 
above into scores for acceptable vs non-acceptable tablets were calculated. For example, for ease of 
swallowing the cut off value of 60 mm divided acceptable and unacceptable tablets on the basis of 
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VAS score given. Ease of swallowing was the parameter with the most sensitive and specific cut off 
(Table 5).  
4 Discussion 
Acceptability of solid oral dosage forms is driven by the ease of swallowing and palatability. Yet, 
there is limited understanding of the sensory parameters which have the largest impact on the 
acceptance of solid dosage forms. This study explored sensory attributes that relate to patient 
experience during the swallowing of a tablet. The participants’ responses were collected on VAS, as 
it is known to be a sensitive tool to measure small differences in sensory perception. Furthermore, 
the acceptability of samples was compared with the VAS results, to define the acceptable and 
unacceptable qualities of tablets.  
The ease of swallowing assessment showed that the addition of a coating onto a tablet enhances the 
ease of swallowing compared to an uncoated one. Also, the uncoated tablet was reported to get 
stuck more often and required more water to swallow, which may relate to its capacity to absorb 
liquid. The liquid penetration of the tablet is directly proportional to its porosity (Esteban et al., 
2017). Thus the high porosity of uncoated tablet favours the effect of capillary ingress of the liquid. 
As a result, lubricant and air are removed from the tablet/mouth interface, which increases the risk 
of adhesion.  
 Additionally, the tablet cores contained insoluble excipients, hence the surface of the uncoated 
tablet is rough in contact with a wet surface. This results in greater friction associated with 
swallowing these tablets. In contrast, a layer of polymer coating reduces the amount of water 
absorbed, thereby maintaining lubrication and reducing friction. In addition, on hydration they form 
a slippery layer that further reduces friction. This hypothesis is supported by a study showing how 
coatings improved the ease of swallowing in vitro, where coated discs with lubricating properties 
needed a reduced force to be moved across ex vivo porcine oesophageal tissue (Smart et al., 2015). 
This explains the fact that the uncoated tablets are perceived to get stuck more often than coated 
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tablets. Age was found to be an important factor in the process of taking tablets. The older 
population (≥ 55 years) reported difficulties with swallowing tablets less often; also they required 
less water to take the sample. As the older population consumes more medicines (Eurostat, 2017), it 
may be argued, that this is a function of experience and training with a range of solid oral dosage 
forms. Compared to the younger group, older participants had a longer duration of swallow. 
Published literature confirms that the passage of the tablet down the throat is longer in older adults 
(Pongpipatpaiboon et al., 2018). The results in this study may have been confounded by difficulties 
with using a timer or dexterity problems, rather than the slowness of swallowing itself. Despite the 
longer duration of the swallow, tablet arrest was not different between the older and younger 
populations. 
The suggested volume of water taken with solid oral medicines is a full glass (Tamboli et al., 2010). In 
the literature, the typical amount consumed with medicines was reported as of 115 mL out of 
150 mL provided (Fuchs, 2009). In this study, the median volume taken was 26.4 mL for coated and 
34.2 mL for uncoated tablets. In all cases the total volume of water used to swallow tablets was less 
than generally recommended. The low volume consumed might be a consequence of the study set 
up. As the participants knew they would have to swallow a number of tablets one after another, so 
they may have tried to minimise their fluid intake.  
Overall, the uncoated tablets in this study were regarded as inferior in terms of palatability to the 
coated ones. The VAS scores showed that the uncoated tablets had a rough, sticky, not slippery 
mouthfeel and unpleasant palatability. Whereas coated tablets showed the opposite sensation. The 
EZ-EZ tablet coating was superior across all parameters. The EZ-EZ coating was reported to be the 
most slippery and smooth, while EZ-EZ and EZ were less sticky than the Opadry coating. This was 
expected, as coatings based on HPMC polymers are known to have muco-adhesive properties 
(Washington, 2001). EZ-EZ and EZ coatings were designed to have low adhesion and high 
slipperiness by addition of polymer combinations and MCT which is oily, to the formulation. Thus, 
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the differences observed in the slipperiness of the tablets were formulation dependent. In line with 
previous reports, addition of a glide-enhancing excipient (xanthan gum) into the coating, it enhances 
slipperiness in vivo (Mahdi and Maraie, 2015).  The coated tablets were consistently ranked as more 
slippery than the uncoated one. 
In this study, several parameters were associated with acceptability: ease of swallowing; amount of 
water taken with the tablet; rank order; roughness; adhesiveness and slipperiness. Thus, these 
parameters can be used as a measure of acceptability. A highly sensitive and specific measure is one 
that accurately separates acceptable from unacceptable tablets. Ease of swallowing and rank order 
were highly sensitive and specific measures of tablet acceptance. Stickiness and roughness were the 
mouthfeel attributes most strongly linked to tablet acceptance. The scaling with the use of cut offs 
provides an insight into what drives the acceptability. Some attributes were more critical than other. 
For example, the VAS cut off of 70 mm for roughness suggested that only samples which were 
undoubtedly smooth were acceptable. While a VAS cut off of 20 mm for stickiness indicates that 
only highly sticky tablets were unacceptable, and slightly sticky tablets were acceptable. Remarkably, 
palatability was not associated with acceptability in this study. The palatability is often related to the 
appreciation of taste. Yet the tablets were designed to be tasteless which may explain why 
palatability was less sensitive measure. This was also shown by the fact that the VAS scores on the 
palatability scale were clustered in the middle of the scale. Importantly, in a presence of bitter drug 
in a tablet the palatability should have significant impact on the acceptability. 
5 Study Limitations 
There were a number of limitations associated with this study. First, the study recruited only 
participants self-assessed as healthy and excluded dysphagic patients or people with diagnosed 
swallowing difficulties. Second, the use of an untrained, non-expert panel has the potential to 
increase the variability of responses to the sensory attributes of tablets. All data were collected on a 
single visit, hence the repeatability of results within a single subject could not be determined. Finally, 
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although visually the tablets were alike the uncoated tablet performed very differently to the coated 
tablets. Therefore, by comparing only coated tablets, a more differentiated picture of the preferred 
coatings might have been achieved. 
6 Conclusions 
This study aimed to investigate the ease of swallowing and oral sensory properties of coated tablets 
to determine how mouthfeel can improve acceptability. It was found that the oral sensory 
properties can be assessed by visual analogue scales. In particular, the presence of a tablet coating 
improved the ease of swallowing, mouthfeel and overall palatability. Uncoated tablets were 
perceived as rough, sticky and not slippery, while the coated tablets were predominantly slippery, 
smooth and pleasant. The extent of palatability improvement was film coating formulation 
dependent with the greatest improvement achieved with the most slippery coating (Opadry EZ 
white coated with clear Opadry EZ). Opadry coating was generally accepted, but had inferior 
mouthfeel scores compared to both Opadry EZ coating options. 
In summary, sensory analysis based on VAS can improve understanding of the factors that influence 
overall acceptability of medicines. The oral sensory features, when related to acceptability using cut 
off values, could be used as references for the testing of new coatings in the future. Specifically, ease 
of swallowing and stickiness were found to be a highly sensitive and specific measure to predict 
tablet acceptance. Notably, palatability was not associated with acceptability, though this case is 
specific for placebo tablets, containing no substance with aversive taste. 
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Figure 1 Example of 100 mm unmarked Visual analogue scale (VAS) 
 
 
  
The product is easy 
to swallow 
The product is 
difficult to swallow 
Please complete the following scale. Mark the scale with X or line to indicate your response: 
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Figure 2 Ease of swallowing VAS scores for all the samples; each ▴ represents one participant, line depicts 
median score (n=83) 
  
  
20 
 
 
Figure 3 Comparison of the four tablet samples in the mouthfeel test (score 0 means negative quality, 100 
positive quality). Brackets indicate statistical significance (p<0.0167) 
 
Table 1.  
Film coating systems (Opadry®) used in this study 
Abbreviation used Film coat Top coat Main ingredients 
Uncoated - - - 
EZ-EZ Opadry EZ white Opadry EZ clear 
HPMC + polysaccharide + 
MCT* 
EZ Opadry EZ white - 
HPMC + polysaccharide + 
MCT* 
Opadry Opadry 03F white - HPMC 
* MCT - medium chain triglycerides 
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Table 2  
Film coating process conditions used to coat the placebo tablets (if roughness was observed in tablets, an 
adjustment in spray rate and pan speed was made to ensure tablets appear similar) 
Parameter Batch 1 Batch 2 Batch 3 
Film Coating Opadry® 
White 
Opadry EZ 
White 
Opadry EZ 
White 
Opadry EZ 
Clear top coat 
Solids (% w/w) 15 15 15 8 
Inlet Temperature (°C) 50 50 50 50 
Bed temperature (°C) - actual 44.6 44.8 46.2 45.5 
Exhaust temperature (°C) 43.3 44.7 44.0 42.2 
Pan speed (rpm) 2.0 - 4.0 3.0 - 4.0 3.0 – 3.5 3.0 - 4.0 
Atomizing pressure (bar) 2.5 3.0 3.0 3.0 
Spray rate (g/min) 24 16 17 21 
Weight gain (%) 3 3 3 1 
Batch size (kg) 8.3 8.3 8.3 8.3 
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Table 3. 
Participant demographics 
Number of participants (n=83) Frequency Percent [%] 
Gender   
      Male 34 41.0 
      Female 49 59.0 
Age (years)   
      <24 10 12.0 
      25-34 13 15.7 
      35-44 11 13.3 
      45-54 7 8.4 
      55-64 10 12.0 
      >65 32 38.6 
Problems with swallowing tablets previously 
      No 60 73.2 
      Yes 22 26.8 
      Missing* 1  
History of taking medicines   
      None daily 34 41.5 
      Between 1-3 daily 32 39.0 
      4 or more daily 16 19.5 
      Missing* 1  
* Participant did not answer the question  
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Table 4.  
Problems reported with swallowing tablets 
* Multiple answers were possible  
  
 Frequency* 
Percent of whole study 
population (n=83) 
Percent of those who stated that have 
problems with swallowing (n=22) 
Size of tablet 18 21.7 81.8 
Taste of tablet 4 4.8 18.2 
Texture of tablet 6 7.2 27.3 
Aftertaste 3 3.6 13.6 
Dry mouth 6 7.2 27.3 
Other 1 1.2 4.5 
Total 38   
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Table 5.  
Results of Mann-Whitney U test for the influence of the parameter on the acceptability, the sensitivity and 
specificity of the cut off (n=83)  
Parameter Mann-Whitney U P value Cut off Sensitivity Specificity 
Ease of swallowing (0 = difficult) 153.5 0.001 60 0.88 0.82 
Water (mL) 214 0.018 40 0.64 0.64 
Time (sec) 263.5 0.186 - - - 
Rank (1= best) 71.5 0.000 3 0.81 1 
Roughness (0 = rough) 145 0.017 70 0.65 0.75 
Stickiness (0 = sticky) 136 0.011 20 0.89 0.63 
Slipperiness (0 = not slippery) 149 0.020 30 0.80 0.63 
Palatability (0 = not pleasant) 258 0.522 - - - 
 
 
 
